Suppr超能文献

诅咒还是良药?醛类作为活性药物成分的可开发性视角。

Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.

机构信息

Genentech, 1 DNA Way, South San Francisco, 94080 California, United States.

出版信息

J Med Chem. 2020 Dec 10;63(23):14357-14381. doi: 10.1021/acs.jmedchem.0c01177. Epub 2020 Sep 29.

Abstract

There is a dichotomy between the increasing utility of aldehydes as tool molecules that bind to "undruggable" protein sites and the designation of the aldehyde functional group as a structural alert by the medicinal chemistry community. Herein we compile information about pharmacologically active aldehydes that are being used in humans. We summarize the learnings from these data, discuss advantages and challenges associated with aldehydes, and derive strategies for the successful development of aldehydes within drug discovery programs.

摘要

醛类作为与“不可成药”的蛋白质靶点结合的工具分子的效用不断增加,而药物化学界则将醛基指定为结构警示基团,这两者之间存在矛盾。在此,我们编译了在人类中使用的具有药理活性的醛类信息。我们总结了这些数据中的经验教训,讨论了醛类的优点和挑战,并得出了在药物发现计划中成功开发醛类的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验